Abstract:Transglutaminase 2 (TG2) is a GTP-binding/protein-crosslinking enzyme that has been investigated as a therapeutic target for Celiac disease, neurological disorders, and aggressive cancers. TG2 has been suggested to adopt two conformational states that regulate its functions: a GTP-bound, closed conformation, and a calcium-bound, crosslinking-active open conformation. TG2 mutants that constitutively adopt an open conformation are cytotoxic to cancer cells. Thus, small molecules that maintain the open conformation of TG2 could offer a new therapeutic strategy. Here, we investigate TG2, using static and time-resolved small-angle X-ray scattering (SAXS) and single-particle cryoelectron microscopy (cryo-EM), to determine the conformational states responsible for conferring its biological effects. We also describe a newly developed TG2 inhibitor, LM11, that potently kills glioblastoma cells and use SAXS to investigate how LM11 affects the conformational states of TG2. Using SAXS and cryo-EM, we show that guanine nucleotide-bound TG2 adopts a monomeric closed conformation while calcium-bound TG2 assumes an open conformational state that can form higher order oligomers. SAXS analysis also suggests how a TG2 mutant that constitutively adopts the open state binds nucleotides through an alternative mechanism to wildtype TG2. Furthermore, we use time-resolved SAXS to show that LM11 increases the ability of calcium to drive TG2 to an open conformation, which is not reversible by guanine nucleotides and is cytotoxic to cancer cells. Taken together, our findings demonstrate that the conformational dynamics of TG2 are more complex than previously suggested and highlight how conformational stabilization of TG2 by LM11 maintains TG2 in a cytotoxic conformational state.

Transglutaminase II: A New Class of GTP-Binding Protein with New Biological Functions

Tissue transglutaminase: a multifunctional and multisite regulator in health and disease

TGM2-mediated Histone Transglutamination is Dictated by Steric Accessibility

Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis

Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments

Tissue Transglutaminase, a Key Enzyme Involved in Liver Diseases.

Defining the conformational states that enable transglutaminase 2 to promote cancer cell survival versus cell death

Conformational Modulation of Tissue Transglutaminase via Active Site Thiol Alkylating Agents: Size Does Not Matter

Structural and mechanistic analysis of Ca2+-dependent regulation of transglutaminase 2 activity using a Ca2+-bound intermediate state

The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial–mesenchymal transition

Emerging Functions beyond Skin

Distinct conformational states enable transglutaminase 2 to promote cancer cell survival versus cell death

Transglutaminase 2 is an RNA-binding protein: Experimental verification and characterisation of a novel transglutaminase feature

Transglutaminase 6: a protein associated with central nervous system development and motor function

Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer

Keratinocyte transglutaminase: differentiation marker and member of an extended family

Plant Transglutaminases: New Insights in Biochemistry, Genetics, and Physiology

Computational analyses of the effect of novel amino acid clusters of human transglutaminase 2 on its structure and function

Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors

Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2

Gαs Slow Conformational Transition Upon GTP Binding and a Novel Gαs Regulator